Dr Lalchandani Labs quarterly results and financials

Dr Lalchandani Labs (BSE 541299)₹6.47−2.12%(9 Nov 2026 close)Healthcare Service Provider

Key facts

In the Mar 2026 quarter (standalone), Dr Lalchandani Labs reported sales of ₹2.12 Cr, down 8.6% from Mar 2025, and net profit of −₹0.12 Cr, down 146.2% year on year. For the year to Mar 2026, sales were ₹4.17 Cr and net profit ₹0.05 Cr.

Sales (Mar 2026): ₹2.12 Cr
Net profit (Mar 2026): −₹0.12 Cr
Sales (FY Mar 2026): ₹4.17 Cr
Net profit (FY Mar 2026): ₹0.05 Cr
EPS (Mar 2026): ₹−0.14
Borrowings (Mar 2026): ₹2.07 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

Dr Lalchandani Labs quarterly results

₹ crore unless stated; each column is a quarter.

Dr Lalchandani Labs Quarterly results
	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Sales	2.75	2.72	2.07	2.12	2.32	2.04	2.12
Expenses	2.49	2.39	1.03	1.58	1.81	1.78	2.01
Operating Profit	0.27	0.34	1.03	0.53	0.50	0.25	0.14
OPM %	9.4%	12.8%	50.0%	25.3%	21.9%	12.7%	6.1%
Other Income	0.00	0.00	0.23	0.00	0.00	0.28	0.00
Interest	0.52	0.12	0.27	0.06	0.04	0.00	0.00
Depreciation	0.33	0.32	0.28	0.27	0.27	0.27	0.28
Profit before tax	−0.60	−0.10	0.72	0.22	0.21	0.27	−0.18
Tax %	0.0%	0.0%	0.0%	23.8%	−35.0%	26.9%	−17.7%
Net Profit	−0.58	−0.08	0.70	0.14	0.26	0.19	−0.12
EPS (Rs)	−0.67	−0.09	0.81	0.16	0.30	0.22	−0.14

Dr Lalchandani Labs profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Dr Lalchandani Labs Profit and loss
	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales	2.78	5.24	6.08	9.75	11.24	5.02	4.79	4.44	4.17
Expenses	2.16	4.05	4.83	7.53	8.82	4.94	4.58	3.51	3.51
Operating Profit	0.63	1.19	1.25	2.23	2.46	0.10	0.21	0.92	0.70
OPM %	22.2%	22.8%	20.7%	22.9%	21.9%	1.8%	4.6%	20.9%	16.5%
Other Income	0.02	0.02	0.00	0.00	0.00	0.00	1.39	0.12	0.00
Interest	0.15	0.13	0.19	0.36	0.61	1.00	0.37	0.10	0.01
Depreciation	0.12	0.34	0.41	0.51	0.58	0.65	0.61	0.55	0.56
Profit before tax	0.37	0.73	0.67	1.38	1.29	−1.57	0.63	0.42	0.11
Tax %	25.0%	26.4%	28.8%	26.3%	28.2%	0.0%	0.0%	−2.4%	30.0%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	1.01	0.00	0.00
Net Profit	0.25	0.52	0.46	1.00	0.92	−1.55	0.61	0.41	0.05
EPS (Rs)	0.43	0.60	0.53	1.15	1.06	−1.78	0.70	0.47	0.06
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Dr Lalchandani Labs balance sheet

₹ crore, at each year end.

Dr Lalchandani Labs Balance sheet
	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	—	2.94	4.35	4.35	4.35	4.35	4.35	4.35	4.35	8.68
Reserves	—	0.41	3.74	4.22	5.24	6.17	4.61	5.23	5.64	5.52
Borrowings	—	1.89	0.91	1.77	4.06	5.17	6.43	3.50	4.08	2.07
Other Liabilities	—	1.00	1.18	1.64	1.61	2.50	2.41	1.98	1.73	1.41
Total Liabilities	—	6.24	10.18	11.98	15.26	18.19	17.80	15.06	15.80	17.68
Fixed Assets	—	2.07	3.29	3.48	5.26	5.77	5.41	4.01	3.52	3.28
CWIP	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	—	0.25	0.25	0.25	0.25	0.25	0.25	0.42	0.28	0.28
Other Assets	—	3.92	6.64	8.25	9.75	12.17	12.14	10.63	12.00	14.12
Inventories	0.19	0.28	0.40	0.51	0.69	1.57	1.53	1.45	1.30	1.43
Trade receivables	0.60	1.13	1.82	3.32	3.97	4.21	4.96	4.69	5.25	6.10
Cash & equivalents	0.04	0.90	2.01	2.24	2.88	3.52	3.09	2.28	3.29	4.13
Total Assets	—	6.24	10.18	11.98	15.26	18.19	17.80	15.06	15.80	17.68

Dr Lalchandani Labs cash flow

₹ crore, for each year.

Dr Lalchandani Labs Cash flow
	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	0.57	−0.44	−0.09	1.18	2.00	0.00	−0.21	0.36	−0.75
Cash from investing activity	−1.28	−1.94	−0.52	−2.25	−1.52	−0.19	0.99	0.05	−0.50
Cash from financing activity	1.56	3.50	0.84	1.70	0.15	−0.22	−1.58	0.57	2.11
Net cash flow	0.86	1.13	0.24	0.65	0.65	−0.44	−0.82	1.02	0.85
Capex	1.32	1.95	0.62	2.30	1.09	0.31	0.11	0.14	0.34
Free cash flow	−0.74	−2.40	−0.72	−1.11	0.92	−0.31	0.75	0.31	−1.10
CFO / OP %	94.0%	−32.1%	5.0%	67.0%	95.0%	0.0%	−100.0%	40.0%	−110.0%

Dr Lalchandani Labs ratios

Working-capital days and returns, by year.

Dr Lalchandani Labs Ratios
	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	149	127	199	149	137	360	357	431	532
Inventory days	167	233	159	69	191	459	255	490	307
Days payable	427	407	355	97	175	404	218	365	110
Cash conversion cycle	−111	−47	2	120	152	414	394	557	729
Working capital days	162	167	206	104	78	188	164	157	461
ROCE %	—	12.1%	8.7%	14.3%	12.8%	−3.7%	−2.7%	2.8%	0.8%

Dr Lalchandani Labs: frequently asked questions

What are the latest quarterly results of Dr Lalchandani Labs?

For the Mar 2026 quarter, Dr Lalchandani Labs reported sales of ₹2.12 Cr, down 8.6% year on year and net profit of −₹0.12 Cr, down 146.2% year on year. The operating margin was 6.1%.

What is the annual revenue of Dr Lalchandani Labs?

Dr Lalchandani Labs' sales for the year to Mar 2026 were ₹4.17 Cr.

What is the net profit of Dr Lalchandani Labs?

Net profit for the year to Mar 2026 was ₹0.05 Cr. Earnings per share over the same trailing period were ₹0.06.

How much debt does Dr Lalchandani Labs have?

Dr Lalchandani Labs reported borrowings of ₹2.07 Cr at Mar 2026, against cash and equivalents of ₹4.13 Cr.

What is the free cash flow of Dr Lalchandani Labs?

Cash from operations was −₹0.75 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹1.10 Cr.

Loading…